Madeline Choi
Vorstandsvorsitzender bei DNAGO.Ai
Vermögen: 17 800 $ am 31.03.2024
Profil
Madeline Choi is currently the Chief Executive Officer at DNAGO.Ai.
Prior to this, she worked as a Secretary at Hi-Great Group Holding Co. from 2020 to 2022.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
31.12.2022 | 1 000 000 ( 1,00% ) | 17 800 $ | 31.03.2024 |
Aktive Positionen von Madeline Choi
Unternehmen | Position | Beginn |
---|---|---|
DNAGO.Ai
DNAGO.Ai Medical/Nursing ServicesHealth Services Part of Oncologix Tech, Inc., DNAGO.Ai is a company that specializes in cell banking technology, specifically in dermal papilla cells. The company is based in Irvine, CA. The company also conducts research in other areas and have a research institute. The CEO of the company is Madeline Choi. DNAGO.Ai was acquired by Oncologix Tech, Inc. on June 30, 2022. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Madeline Choi
Unternehmen | Position | Ende |
---|---|---|
HI-GREAT GROUP HOLDING COMPANY | Unternehmenssekretär | 22.09.2022 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Hi-Great Group Holding Co. | |
DNAGO.Ai
DNAGO.Ai Medical/Nursing ServicesHealth Services Part of Oncologix Tech, Inc., DNAGO.Ai is a company that specializes in cell banking technology, specifically in dermal papilla cells. The company is based in Irvine, CA. The company also conducts research in other areas and have a research institute. The CEO of the company is Madeline Choi. DNAGO.Ai was acquired by Oncologix Tech, Inc. on June 30, 2022. | Health Services |